Follow The Filings

PACB Pacific Biosciences Calif Inc.

Industrials, filed as PACIFIC BIOSCIENCES CALIF IN (COM), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q3

  • 2 Owners
  • Max 0.4%
  • $71M
  • 1 exit 1 small

In 2026 Q3 Murray Stahl sold out of Pacific Biosciences Calif.

Who owns this now

Largest portfolio weights among holders, up to 0.4% (Cathie Wood, ARK Investment Management). Not free-float ownership.

  1. Cathie Wood Reduce 0.41%

Who owns PACB

Sorted by value, long equity only, as of 2026 Q3.

History
Cathie Wood, ARK Investment Management 0.41% Small trim −0.1% 29,749,893 $71M History
Farallon Capital Management <0.01% Hold 14,200 $34K History
Murray Stahl, Horizon Kinetics Asset Management exited 2026 Q3 Last 2026 Q2 <0.01% Exit 0.00% 10,068 $17K History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by PACB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PACB insider trades
  • None no insider bought on the open market
  • $33K sold by 1 insider outside a trading plan
  • $2.1M sold by 1 insider under 10b5-1 plans
  1. Kathy Ordonez Director
    Sale
    $33K 18,595 shares at $1.78 4.6% of stake
    Traded Nov 17 Filed Nov 19
  2. James R. Gibson II See Remarks
    Planned sale
    $2.1M 661,815 shares at $3.11 38% of stake
    Traded Oct 6 Filed Oct 8

Also filed in the last 12 months, not counted as buying or selling: 11 sales to cover taxes, 8 stock grants, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
424B5
8-K 1.01,9.01
SCHEDULE 13G —
SCHEDULE 13G —
10-Q
8-K 2.02,5.02,9.01
SCHEDULE 13G/A —
10-Q
8-K 2.02,2.05,5.02,7.01,9.01
8-K 5.02
8-K 5.02,5.07,9.01
DEFA14A
10-Q
8-K 2.02,9.01
DEF 14A
DEFA14A
SCHEDULE 13G/A —
8-K 5.02,7.01
8-K 5.02,7.01,9.01

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Gross profit $52.78M $37.28M $45.78M
Net income -$306.74M -$309.85M -$546.38M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $742.05M $495.68M $375.05M
Total non-current assets * $1B $0.765B $0.409B
Total assets $1.75B $1.26B $0.784B
Total current liabilities $95.03M $66.3M $72.83M
Total non-current liabilities * $949.68M $687.55M $705.9M
Total equity $701.3M $506.59M $5.35M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$259.17M -$206.06M -$111.21M
Cash from investing $4.6M $124M $115.45M
Cash from financing $108.89M -$42.99M $3.43M
Net change in cash -$145.68M -$125.04M $7.67M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf